More Medical Developments International Limited news
Medical Developments International LimitedASX: MVP

MVP and MundiPharma cease Australian licensing agreement

Oct 30, 2020 at 1:01 AM EDT · Issued by Medical Developments International Limited

Filed with ASX · Oct 30, 2020 at 1:01 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/mvp-and-mundipharma-cease-australian-licensing-agreement

Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19↗

Medical Developments International Limited on 6ix

Earlier from Medical Developments International

  • Chairmans and CEOs Address to ShareholdersOct 27, 2020
  • Appointment of CEO - Brent MacGregorOct 14, 2020
  • Appointment of Non-Executive Director - Gordon NaylorOct 14, 2020
  • Medical Developments to take control of EU marketsAug 18, 2020
  • S&P DJI Announces June 2020 Quarterly RebalanceJun 11, 2020

Later from Medical Developments International

  • EU Transition and Trading UpdateDec 3, 2020
  • MVP completes $25m placementDec 13, 2020
  • MVP Capital Raising PresentationDec 14, 2020
  • Share Purchase PlanDec 17, 2020
  • Results of SPPJan 21, 2021
All Medical Developments International news releases↗

Follow Medical Developments International into a list and get an email when it puts out news.

Follow Medical Developments International
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer